About this trial
The aim of this study is to investigate the hypothesis that the intraoperative use of the nociception level index NOL can reduce opioid consumption in adult patients undergoing elective laparoscopic surgeries under general anesthesia, as well as to explore its effect on post-operative pain and patient recovery.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Adult patients undergoing planned laparoscopic surgery under general anesthesia.
Disqualifiers
Emergency surgery.
Pregnancy.
Drug or alcohol abuse in the last 6 months.
Chronic opioid use or patients with chronic pain.
Trial design
Parallel
Treatments tested in this trial
Nociception level index (NOL™)
DeviceIf a NOL value \>25 persists for \>1 minute a bolus of iv fentanyl 0.5mcg/kg will be given and reassessment of the NOL value will continue every 5 minutes. If NOL index value: 10-25 is not reached within 10 minutes, fentanyl 0.5mcg/kg iv is re-administered.
Fentanyl
Other interventionBolus doses of iv fentanyl 0.5 mcg/kg will be administered based on the judgment of the anesthesiologist in charge.
Treatment groups
Trial outcomes
Primary outcomes
Intraoperative total consumption of opioids
Intraoperative total consumption of opioids will be calculated in all patients.
Secondary outcomes
Postoperative administration of opioids in PACU
Total consumption of opioids will be calculated in all patients
Intensity of postoperative pain in PACU
In PACU, intensity of postoperative pain will be assessed every 15 minutes with the Visual analogue scale, a 10 points scale (0= no pain and 10= worst pain)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.